All companies
Visit website
Add Your Labs
OperatingTrueGen Health, Inc.
Healthcare · Biotech · Founded 2021
Next generation in medical laboratory software
Post-money valuation ⓘ
$7.1M
As of Dec 2022 · from Add Your Labs Common Stock 2 · pre-money + amount raised, not a traded price
Total raised
$48,169
Across 2 rounds since 2022
Latest share price
$2.00
Add Your Labs Common Stock 2 offering price
Financials
FY2019–FY2022 · from SEC filings · hover any figure for its source$0
2019
$118K
−$32K
2020
$220K
−$20K
2021
$110K
−$134K
2022
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019
FY2020
FY2021
FY2022
Income statement
Revenue
$0
$117,588
$220,483
$109,502
Cost of goods sold
$0
$56,711
$81,267
$91,990
Gross margin
—
52%
63%
16%
Net income
$0
-$31,979
-$20,142
-$134,181
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$0
$17,621
$771
$58,172
Accounts receivable
$0
$0
$220,483
$109,502
Total assets
$0
$220,907
$248,760
$392,195
Short-term debt
$0
$9,785
$14,070
$45,389
Long-term debt
$0
$0
$0
$0
Total liabilities
$0
$9,785
$14,070
$45,389
Other
Headcount
—
2
2
2
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$7.1M
post-money
Add Your Labs Common Stock 2
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $48.2K / $124KInvestors 39Post-money $7.1M
Raised $0 / $249.9K
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 1 of 5 annual reports (FY2021–FY2025)
39 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 9 filings on EDGARSource: ManualCIK 0001901311Share price $2.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.